search
Back to results

Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty (EEIPF)

Primary Purpose

ERAS, Frailty

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ERAS exercise
No ERAS exercise
Sponsored by
First Affiliated Hospital of Chongqing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for ERAS focused on measuring ERAS, Frailty, Exercise, Activity

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients receiving elective laparoscopic colorectal surgery.
  • 18≤age≤100 years old, no gender limit;
  • The ASA score is between I and Ⅲ;
  • Clearly understand and voluntarily participate in the study, and sign an informed consent form.

Exclusion Criteria:

  • Emergency surgery;
  • Those with a history of cognitive dysfunction;
  • Those with a history of neuromuscular diseases,;
  • American Society of Anesthesiologists class ⩾IV;
  • Those with a history of spontaneous pneumothorax, coagulation dysfunction,
  • Acute and systemic infectious diseases, moderate or higher fever;
  • Pregnant women;
  • History of drug abuse;
  • Those who judged by the physician in charge to be unsuitable for ERAS-exercise;
  • Other severe cardio-pulmonary diseases that would affect the 6MWD
  • Those failure to obtain informed consent.

Sites / Locations

  • the First Affiliated Hospital of Chongqing Medical University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

ERAS exercise in perioperative period.

No ERAS exercise in perioperative period.

Arm Description

The patients take ERAS exercise from hospitalization to 30 days after operation.

The patients do not take ERAS exercise in perioperative period.

Outcomes

Primary Outcome Measures

Frailty status
Frailty status (i.e. robust, prefrail or frail) measured using the Fried's Frailty Phenotype (FP) scores. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.

Secondary Outcome Measures

Change in gait speed
This outcome will be measured using the 5-meter walk test.
Handgrip strength
Handgrip strength will be measured using a dynamometer.
Perioperative functional capacity
The 6-minute walk distance (6MWD) test is a non-encouraged test performed in a 30 meters long flat corridor, where the participant is instructed to walk as far as possible, back and forth around two cones, with the permission to slow down, rest, or stop if needed. Ambulation was assessed via the 6MWD test following standardized procedures by measuring the 6MWD in meters. Participants were not permitted to use assistive devices (walker, long leg braces, or short leg braces) during the 6MWD test. Participants with confirmed loss of ambulation at a particular visit were assigned a 6MWD result of 0.
Patient mood state
This outcome will be assessed using Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.
Nutritional status
This outcome will be assessed using Nutritional Risk Screening 2002 (NRS-2002): The patients were classified as being nutritionally risk (NRS+): total score ≥ 3 or nutritionally risk-free (NRS-): total score < 3 according to NRS 2002 results.
Short-term recovery quality
This outcome will be measured using 9-item quality of recovery(QoR-9) score.The QoR-9 is a 9-item score evaluating both physical and mental well-being by assessing five dimensions: emotional state, physical comfort, psychological support, physical independence and pain. Each of the 9 items are scored by the patient from 0 (worst score) to 2 (best score), giving a lowest possible score of 0 (worst outcome), and a highest possible score of 18 (best outcome).
Postoperative Complications
Postoperative Complications evaluated by Clavien- Dindo Score.Nine domains are evaluated: Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, wound, haematological and pain. Each domain is graded between grade I and V (death of a patient).
Postoperative 30-day mortality
Rate of Mortality among study patients
Highest VAS Pain Score at Rest
Post-operative pain scores at rest, as assessed by Visual Analog Pain Scale (VAS) will be the primary outcome measured. Postoperative pain at rest will be defined as the highest VAS pain score reported by each patient at any time. Pain score is from 0 (no hurt) to 10 (hurts worst).
Highest VAS Pain Score during Exercise
Post-operative pain scores during Exercise, as assessed by Visual Analog Pain Scale (VAS) will be the primary outcome measured. Postoperative pain during Exerciset will be defined as the highest VAS pain score reported by each patient at any time. Pain score is from 0 (no hurt) to 10 (hurts worst).

Full Information

First Posted
March 19, 2021
Last Updated
July 14, 2021
Sponsor
First Affiliated Hospital of Chongqing Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT04964856
Brief Title
Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty
Acronym
EEIPF
Official Title
Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty of Patients Undergoing Elective Surgery:a Randomized Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 1, 2021 (Actual)
Primary Completion Date
December 1, 2021 (Anticipated)
Study Completion Date
February 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
First Affiliated Hospital of Chongqing Medical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
A randomized, controlled, clinical trial on the efficacy of ERAS exercise improve perioperative frailty in patients undergoing elective laparoscopic colorectal surgery Objective to evaluate the efficacy of ERAS exercise improve perioperative frailty in patients undergoing elective laparoscopic colorectal surgery Participants: Patients undergoing elective laparoscopic colorectal surgery over 18 years old. The research intervention was ERAS exercise The study design was a randomized, parallel controlled trial ERAS exercise in perioperative period as the experimental group. No ERAS exercise group was the control group. The sample size was estimated according to the main efficacy index ( the attenuation of frailty after 7 days surgery) of this study. It was assumed that the attenuation of frailty in the ERAS exercise group was better than that of the control group. The parameters were set as test level (alpha) of 0.050 using a two-sided two-sample unequal-variance t-test, β = 0.9, according to the results of previous clinical trials and combined with literature, the population mean difference was 0.6 with standard deviations of 0.8 for the experimental group and 0.8 for the control group. the experimental group: the control group was 1:1, 39 cases in each group, considering the 20% shedding rate, 49 cases in the experimental group and 49 cases in the control group were selected. The experimental group The patients take ERAS exercise from hospitalization to 30 days after operation. The control group The patients do not take ERAS exercise in perioperative period. Efficacy evaluation The primary endpoint of the study was the attenuation of frailty via Frailty Phenotype (FP) between before surgery and 7days, 30 days after surgery. Secondary endpoints included the 6-minute walk test (6MWT),nutritional risk screening (NRS2002), anxious and depressive states, activities of daily living (ADL),postoperative complications and mortality,short-term recovery quality,postoperative pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ERAS, Frailty
Keywords
ERAS, Frailty, Exercise, Activity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
98 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ERAS exercise in perioperative period.
Arm Type
Experimental
Arm Description
The patients take ERAS exercise from hospitalization to 30 days after operation.
Arm Title
No ERAS exercise in perioperative period.
Arm Type
Sham Comparator
Arm Description
The patients do not take ERAS exercise in perioperative period.
Intervention Type
Behavioral
Intervention Name(s)
ERAS exercise
Intervention Description
Take ERAS exercise twice a day from hospitalization to 30 days after surgery
Intervention Type
Behavioral
Intervention Name(s)
No ERAS exercise
Intervention Description
Don't take ERAS exercise in perioperative period
Primary Outcome Measure Information:
Title
Frailty status
Description
Frailty status (i.e. robust, prefrail or frail) measured using the Fried's Frailty Phenotype (FP) scores. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.
Time Frame
Change from Baseline Fried's Frailty Phenotype scores at 30 days postoperatively
Secondary Outcome Measure Information:
Title
Change in gait speed
Description
This outcome will be measured using the 5-meter walk test.
Time Frame
baseline, at 30 days postoperatively
Title
Handgrip strength
Description
Handgrip strength will be measured using a dynamometer.
Time Frame
baseline, at 30 days postoperatively
Title
Perioperative functional capacity
Description
The 6-minute walk distance (6MWD) test is a non-encouraged test performed in a 30 meters long flat corridor, where the participant is instructed to walk as far as possible, back and forth around two cones, with the permission to slow down, rest, or stop if needed. Ambulation was assessed via the 6MWD test following standardized procedures by measuring the 6MWD in meters. Participants were not permitted to use assistive devices (walker, long leg braces, or short leg braces) during the 6MWD test. Participants with confirmed loss of ambulation at a particular visit were assigned a 6MWD result of 0.
Time Frame
baseline, at 30 days postoperatively
Title
Patient mood state
Description
This outcome will be assessed using Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.
Time Frame
baseline and 7th day postoperatively
Title
Nutritional status
Description
This outcome will be assessed using Nutritional Risk Screening 2002 (NRS-2002): The patients were classified as being nutritionally risk (NRS+): total score ≥ 3 or nutritionally risk-free (NRS-): total score < 3 according to NRS 2002 results.
Time Frame
baseline, at 30 days postoperatively
Title
Short-term recovery quality
Description
This outcome will be measured using 9-item quality of recovery(QoR-9) score.The QoR-9 is a 9-item score evaluating both physical and mental well-being by assessing five dimensions: emotional state, physical comfort, psychological support, physical independence and pain. Each of the 9 items are scored by the patient from 0 (worst score) to 2 (best score), giving a lowest possible score of 0 (worst outcome), and a highest possible score of 18 (best outcome).
Time Frame
baseline, 1st, 2nd, 3rd and 7th day postoperatively
Title
Postoperative Complications
Description
Postoperative Complications evaluated by Clavien- Dindo Score.Nine domains are evaluated: Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, wound, haematological and pain. Each domain is graded between grade I and V (death of a patient).
Time Frame
30 days postoperatively
Title
Postoperative 30-day mortality
Description
Rate of Mortality among study patients
Time Frame
30 days postoperatively
Title
Highest VAS Pain Score at Rest
Description
Post-operative pain scores at rest, as assessed by Visual Analog Pain Scale (VAS) will be the primary outcome measured. Postoperative pain at rest will be defined as the highest VAS pain score reported by each patient at any time. Pain score is from 0 (no hurt) to 10 (hurts worst).
Time Frame
baseline, 1st, 2nd, 3rd and 7th day postoperatively
Title
Highest VAS Pain Score during Exercise
Description
Post-operative pain scores during Exercise, as assessed by Visual Analog Pain Scale (VAS) will be the primary outcome measured. Postoperative pain during Exerciset will be defined as the highest VAS pain score reported by each patient at any time. Pain score is from 0 (no hurt) to 10 (hurts worst).
Time Frame
baseline, 1st, 2nd, 3rd and 7th day postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients receiving elective laparoscopic colorectal surgery. 18≤age≤100 years old, no gender limit; The ASA score is between I and Ⅲ; Clearly understand and voluntarily participate in the study, and sign an informed consent form. Exclusion Criteria: Emergency surgery; Those with a history of cognitive dysfunction; Those with a history of neuromuscular diseases,; American Society of Anesthesiologists class ⩾IV; Those with a history of spontaneous pneumothorax, coagulation dysfunction, Acute and systemic infectious diseases, moderate or higher fever; Pregnant women; History of drug abuse; Those who judged by the physician in charge to be unsuitable for ERAS-exercise; Other severe cardio-pulmonary diseases that would affect the 6MWD Those failure to obtain informed consent.
Facility Information:
Facility Name
the First Affiliated Hospital of Chongqing Medical University
City
Chongqing
State/Province
Chongqing
ZIP/Postal Code
400016
Country
China

12. IPD Sharing Statement

Learn more about this trial

Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty

We'll reach out to this number within 24 hrs